Haralampos Milionis
Cardiology — University Hospital of Ioannina, Greece
Haralampos Milionis
LeadR Profile
Cardiology
Subspecialties: Infectiology - Gastroenterology - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 505
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Effect of clarithromycin on the circulating inflammatory proteome in community-acquired pneumonia: a secondary analysis of the ACCESS trial. immunomodulation, clarithromycin, pneumonia, sepsis, proteomics, therapeutics, proteome, community-acquired pneumonia | Chest | 2026 | 0 |
| Cellular Crosstalk at the Gut-Liver Interface in Liver Cirrhosis: Epithelial Barrier Failure, Bacterial Translocation and Immune Activation as a Bidirectional Network. cells, liver cirrhosis, liver, bacterial translocation, immunity, mucosal, bacteria | Cells | 2026 | 0 |
| Emerging Immune Cell Biomarkers in Primary Membranous Nephropathy: Immune Cell Profiling During Anti-CD20 B Cell-Targeted Therapy. glomerulonephritis, membranous, cells, biomarkers, rituximab, therapeutics, monitoring, immunologic, b-lymphocytes | Int J Mol Sci | 2026 | 0 |
| Serum Lipoprotein(a) and Hemorrhagic Stroke Risk: A Systematic Review and Meta-Analysis. cerebral hemorrhage, hemorrhage, ischemic stroke, serum, stroke, lipoproteins, case-control studies, hemorrhagic stroke, cohort studies, subarachnoid hemorrhage, cerebrovascular disorders, lipoprotein(a) | J Stroke Cerebrovasc Dis | 2026 | 0 |
| Prevalence, Clinical Characteristics, and Therapeutic Underachievement in Familial Hypercholesterolemia: Results from the GRegistry-FH Population-Based Study in Greece. hyperlipoproteinemia type ii, phenotype, underachievement, prevalence, therapeutics, hypercholesterolemia | J Clin Med | 2026 | 0 |
Clinical Studies 34
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Biomarker Guided Early Clarithromycin Treatment To Prevent Sepsis Progression In Community Acquired Pneumonia The REACT Randomized Clinical Trial 2023-507295-40-00 — clarithromycin, biomarkers, pneumonia, sepsis, therapeutics, community-acquired pneumonia | Phase 3 | Recruiting | 2024 |
| Study to evaluate efficacy and safety of inclisiran in children aged 6 to under 12 years of age with heterozygous familial hypercholesterolemia 2024-514594-21-00 — hyperlipoproteinemia type ii, cholesterol, ldl, safety, aged, cholesterol, child, hypercholesterolemia | Phase 3 | Recruiting | 2025 |
| A Phase 3 Placebo controlled Study of Milvexian after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack 2022-501176-26-00 — safety, ischemic stroke, stroke, ischemic attack, transient, factor xia, factor xia inhibitor | Phase 3 | Active not recruiting | 2023 |
| Prevention of Recurrent C difficile Infection Study with AZD5148 Monoclonal Antibody 2025-521416-19-00 — safety, clostridioides, clostridioides difficile, antibodies, monoclonal, infections | Phase 2 | Recruiting | 2026 |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME CV) 2024-516652-18-00 — cardiovascular diseases, obesity, therapeutics, overweight | Phase 3 | Recruiting | 2025 |
LeadR Networks
Main global connection map